Quotient Limited - Ordinary Shares (QTNT): Price and Financial Metrics


Quotient Limited - Ordinary Shares (QTNT)

Today's Latest Price: $6.98 USD

0.23 (-3.19%)

Updated Dec 3 12:38pm

Add QTNT to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 143 in Medical - Devices & Equipment

See all "A" rated Strong Buy stocks

QTNT Stock Summary

  • With a price/sales ratio of 17.5, Quotient Ltd has a higher such ratio than 90.58% of stocks in our set.
  • Equity multiplier, or assets relative to shareholders' equity, comes in at 58.98 for Quotient Ltd; that's greater than it is for 99.44% of US stocks.
  • Shareholder yield, a measure of how much is returned to shareholders via dividends and share repurchases, for QTNT comes in at -23.44% -- higher than that of only 13.83% of stocks in our set.
  • Stocks that are quantitatively similar to QTNT, based on their financial statements, market capitalization, and price volatility, are MCRB, CYTK, BHC, KFS, and KODK.
  • Visit QTNT's SEC page to see the company's official filings. To visit the company's web site, go to quotientbd.com.

QTNT Stock Price Chart Interactive Chart >

Price chart for QTNT

QTNT Price/Volume Stats

Current price $6.98 52-week high $10.38
Prev. close $7.21 52-week low $2.39
Day low $6.97 Volume 149,542
Day high $7.26 Avg. volume 819,241
50-day MA $5.51 Dividend yield N/A
200-day MA $6.25 Market Cap 705.13M

Quotient Limited - Ordinary Shares (QTNT) Company Bio


Quotient Limited develops, manufactures, and commercializes conventional reagent products used for blood grouping in the transfusion diagnostics market worldwide. The company was founded in 2007 and is based in Penicuik, the United Kingdom.


QTNT Latest News Stream


Event/Time News Detail
Loading, please wait...

QTNT Latest Social Stream


Loading social stream, please wait...

View Full QTNT Social Stream

Latest QTNT News From Around the Web

Below are the latest news stories about Quotient Ltd that investors may wish to consider to help them evaluate QTNT as an investment opportunity.

Quotient prices upsized share offering at $4.25

Quotient (QTNT) slips 2% after-hours after pricing upsized $75M (from $60M) public offering. The Company is offering 17,647,059 ordinary shares at $4.25/share, a discounted price from yesterday's close of $4.82.Underwriters' over-allotment is an additional 2,647,058 shares.Expected net proceeds of ~$69.9M will be used to fund the ongoing development of MosaiQ, for working...

Seeking Alpha | September 11, 2020

Quotient reboots distribution deal with Ortho

Quotient Limited (QTNT) inks a binding letter of intent with Ortho Clinical Diagnostics terminating their former distribution agreement and related contracts and resolving their disputes over the deal.The parties have established a new agreement under which Quotient will develop an immunohematology ((IH)) MosiaQ microarray optimized for the transfusion market. It...

Seeking Alpha | September 8, 2020

Quotient Announces Equity Awards

JERSEY, Channel Islands, July 23, 2020 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company (the Company), headquartered in Eysins, Switzerland today announced that Dr. Isabelle Buckle, Ph.D. and Dr. Catherine Larue, Ph.D. will join the Company’s Board of Directors, effective September 1, 2020. In connection with the planned appointments, on September 1, 2020, Quotient will grant Dr. Buckle and Dr Larue each share options providing for the right to purchase $100,000 of Quotient’s ordinary shares. The grants, which will be issued outside of Quotient’s 2014 Stock Incentive Plan, were approved by Quotient’s Board of Directors and the Remuneration Committee of the Board of Directors pursuant to the inducement grant exception under Nasdaq Rule 5635(c)(4...

Yahoo | July 23, 2020

Quotient Announces Appointment of Two New Board Members

JERSEY, Channel Islands, July 23, 2020 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company (the Company), headquartered in Eysins, Switzerland, today announced changes in the composition of its board of directors that will take effect later this year.  Two of the Company's directors will be leaving the board and, effective September 1, 2020, two new directors will be joining. The new board members are Dr. Isabelle Buckle, Ph.D. and Dr. Catherine Larue, Ph.D.Dr. Buckle currently serves as Executive Vice-President of Technology Transfer and Industrial Partnership at Institut Pasteur in Paris, France. Previously, Dr. Buckle served as Global Vice President, Clinical Mass Spectrometry at Bruker Daltonics. Prior to that, she was CEO and Chairman of ...

Yahoo | July 23, 2020

Edited Transcript of QTNT.OQ earnings conference call or presentation 9-Jun-20 12:00pm GMT

Q4 2020 Quotient Ltd Earnings Call

Yahoo | July 21, 2020

Read More 'QTNT' Stories Here

QTNT Price Returns

1-mo 29.26%
3-mo 59.36%
6-mo 6.40%
1-year -22.27%
3-year 48.51%
5-year -53.87%
YTD -26.60%
2019 55.39%
2018 23.64%
2017 2.27%
2016 -69.75%
2015 -11.11%

Continue Researching QTNT

Want to see what other sources are saying about Quotient Ltd's financials and stock price? Try the links below:

Quotient Ltd (QTNT) Stock Price | Nasdaq
Quotient Ltd (QTNT) Stock Quote, History and News - Yahoo Finance
Quotient Ltd (QTNT) Stock Price and Basic Information | MarketWatch


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.7905 seconds.